Enhanced laboratory surveillance study of Campylobacter species in England
Journal of Medical Microbiology · 2025
DOI: 10.1099/jmm.0.002017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Microbiology, 2025. Verfasst von Craig Swift und 7 weiteren Autor:innen. Beteiligte Einrichtung: UK-Health Security Agency, London, England, UK. Hauptthemen laut MEDLINE: Campylobacter Infections, Campylobacter. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Campylobacteriosis is the leading cause of gastroenteritis worldwide, and Campylobacter species are the most frequently reported zoonotic, bacterial foodborne pathogens in England. Gap statement. Currently, less than 2.0% of Campylobacter isolates in England undergo strain identification and typing, resulting in limited insight into their molecular epidemiology.
Aim
To assess the feasibility of using high-throughput whole-genome sequencing (WGS) to generate data for microbiological and epidemiological analysis by the implementation of a 3-month enhanced laboratory surveillance for Campylobacter spp. in England, and to make recommendations for improving the current Campylobacter surveillance strategies. Methodology. All diagnostic laboratories in England were encouraged to refer isolates of Campylobacter spp. for WGS over a 3-month period (7 June–31 August 2021).
Results
Over 6,000 Campylobacter species isolates were characterized, of which 87.5% were successfully identified as Campylobacter jejuni and 8.1% as Campylobacter coli . Just over half of the isolates were referred from patients who were male (53%), and C. coli isolates tended to be from older patients than C. jejuni , with median ages of 55 and 44 years, respectively. The most common multi-locus sequencing type clonal complex identified was ST-21, and within this, the sequencing type ST6175 was the most frequently identified, of which 96.8% were predicted to carry antimicrobial resistance determinants, inferring reduced susceptibility to both ciprofloxacin and tetracycline. The four largest C. jejuni 5-single nucleotide polymorphism (SNP) clusters, associated with the larger clonal complexes and sequence type groups (ST6175, ST48, ST6175 and ST5136), accounted for 23.8% ( n =1,150/4,838) of SNP typable isolates. Conversely, 28.4% and 39.5% of isolates C. jejuni and C. coli, respectively, appeared to be sporadic, with each isolate assigned a unique SNP address at the 5-SNP level.
Conclusion
WGS enabled identification of genetically related clusters of Campylobacter isolates in almost real time and shows potential for monitoring of inferred antimicrobial resistance. However, unlocking its full potential requires referral of sufficient and representative isolates for sequencing with parallel epidemiological data collection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UK-Health Security Agency, London, England, UK.
Zitieren
APA
Swift, C., Crewdson, A., Chan, Y. W., Painset, A., Douglas, A., Gokool, S., Jenkins, C., & Godbole, G. (2025). Enhanced laboratory surveillance study of Campylobacter species in England. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.002017
Vancouver
Swift C, Crewdson A, Chan YW, Painset A, Douglas A, Gokool S, et al. Enhanced laboratory surveillance study of Campylobacter species in England. Journal of Medical Microbiology. 2025. doi:10.1099/jmm.0.002017
BibTeX
@article{Swift2025,
author = {Swift, Craig and Crewdson, Adam and Chan, Yung-Wai and Painset, Anais and Douglas, Amy and Gokool, Suzanne and Jenkins, Claire and Godbole, Gauri},
title = {Enhanced laboratory surveillance study of Campylobacter species in England},
journal = {Journal of Medical Microbiology},
year = {2025},
doi = {10.1099/jmm.0.002017}
}
EUVIMED